Michael Gelband’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Michael Gelband’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,853	Closed	-$1.38M	–	2592
2022 Q1	$1.38M	Buy	12,853 +6,813	+113%	+$1.07M	0.02%	960
2021 Q4	$1.51M	Buy	+6,040	New	+$1.34M	0.02%	877

Other funds holding SNCE

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

GCM

Glynn Capital Management Menlo Park, California $363M AUM 65.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Qualcomm Inc San Diego, California $32.1M AUM 5.35% 1-Year Est. Return

Michael Gelband's SNCE Position: Q2 2022 in Review

Michael Gelband sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q2 2022, closing a stake of 12,853 shares — an estimated $1.38M sold.

Michael Gelband first reported a position in SNCE in Q4 2021 and held it in 2 quarters. The position peaked at $1.51M in Q4 2021. 76 funds tracked by Wall St. Rank hold SNCE as of Q2 2022.

Michael Gelband reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Michael Gelband sold 12,853 Science 37 Holdings, Inc. Common Stock shares in Q2 2022, an estimated $1.38M.
Michael Gelband first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Michael Gelband's Science 37 Holdings, Inc. Common Stock position peaked at $1.51M in Q4 2021.
76 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.